Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials.
Gasparri ML, Kuehn T, Ruscito I, Zuber V, Di Micco R, Galiano I, Navarro Quinones SC, Santurro L, Di Vittorio F, Meani F, Bassi V, Ditsch N, Mueller MD, Bellati F, Caserta D, Papadia A, Gentilini OD. Gasparri ML, et al. Among authors: di micco r, di vittorio f. Cancers (Basel). 2021 Apr 24;13(9):2056. doi: 10.3390/cancers13092056. Cancers (Basel). 2021. PMID: 33923153 Free PMC article. Review.
Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
Di Micco R, Zuber V, Fiacco E, Carriero F, Gattuso MI, Nazzaro L, Panizza P, Gianolli L, Canevari C, Di Muzio N, Pasetti M, Sassi I, Zambetti M, Gentilini OD. Di Micco R, et al. Among authors: di muzio n. Eur J Surg Oncol. 2019 Jun;45(6):969-975. doi: 10.1016/j.ejso.2019.01.219. Epub 2019 Jan 31. Eur J Surg Oncol. 2019. PMID: 30744944
Corrigendum to "Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype" [Eur. J. Surg. Oncol. 45, (6) (2019) 969-975].
Di Micco R, Zuber V, Fiacco E, Carriero F, Gattuso MI, Nazzaro L, Panizza P, Gianolli L, Canevari C, Di Muzio N, Pasetti M, Sassi I, Zambetti M, Gentilini OD. Di Micco R, et al. Among authors: di muzio n. Eur J Surg Oncol. 2019 Sep;45(9):1754. doi: 10.1016/j.ejso.2019.07.007. Epub 2019 Jul 13. Eur J Surg Oncol. 2019. PMID: 31307816 No abstract available.
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.
Viale G, Licata L, Sica L, Zambelli S, Zucchinelli P, Rognone A, Aldrighetti D, Di Micco R, Zuber V, Pasetti M, Di Muzio N, Rodighiero M, Panizza P, Sassi I, Petrella G, Cascinu S, Gentilini OD, Bianchini G. Viale G, et al. Among authors: di muzio n, di micco r. Oncologist. 2020 Jul;25(7):e1013-e1020. doi: 10.1634/theoncologist.2020-0316. Epub 2020 May 26. Oncologist. 2020. PMID: 32412693 Free PMC article.
What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of view.
Gasparri ML, Poortmans P, Banys-Paluchowski M, Bonci EA, Di Micco R, Condorelli R, Matrai Z, Dubsky P, Gentilini OD, Kuehn T. Gasparri ML, et al. Among authors: di micco r. EClinicalMedicine. 2021 Jan 14;31:100708. doi: 10.1016/j.eclinm.2020.100708. eCollection 2021 Jan. EClinicalMedicine. 2021. PMID: 33490932 Free PMC article.
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.
Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M, Paluchowski P, Solbach C, Blohmer JU, Kühn T, The Axsana Study Group. Banys-Paluchowski M, et al. Among authors: di micco r. Cancers (Basel). 2021 Mar 29;13(7):1565. doi: 10.3390/cancers13071565. Cancers (Basel). 2021. PMID: 33805367 Free PMC article. Review.
PET/MRI for Staging the Axilla in Breast Cancer: Current Evidence and the Rationale for SNB vs. PET/MRI Trials.
Di Micco R, Santurro L, Gasparri ML, Zuber V, Cisternino G, Baleri S, Morgante M, Rotmensz N, Canevari C, Gallivanone F, Scifo P, Savi A, Magnani P, Neri I, Ferjani N, Venturini E, Losio C, Sassi I, Bianchini G, Panizza P, Gianolli L, Gentilini OD. Di Micco R, et al. Cancers (Basel). 2021 Jul 16;13(14):3571. doi: 10.3390/cancers13143571. Cancers (Basel). 2021. PMID: 34298781 Free PMC article. Review.
101 results